The trajectory of Viagra presents a complex picture for shareholders. While the initial launch generated substantial gains, the lapse of its patent opened the door to cheaper competitors, dramatically eroding sales. https://dirstop.com/story28937171/the-copyright-and-pharma-a-volatile-investment